Clinical Trial Update: Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating cisplatin and etoposide with or without veliparib in extensive-stage small cell lung cancer has completed recruitment with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Carcinoma
• Large Cell Lung Carcinoma
• Neuroendocrine Carcinoma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• Veliparib (veliparib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Extensive Stage Small Cell Lung Carcinoma, Large Cell Lung Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-02-05